Afadin is a scaffold protein repressing insulin action via HDAC6 in adipose tissue

Afadin 是一种支架蛋白,通过脂肪组织中的 HDAC6 抑制胰岛素作用

阅读:7
作者:Morten Lundh, Patricia Ss Petersen, Marie S Isidor, Dolly Nm Kazoka-Sørensen, Kaja Plucińska, Farnaz Shamsi, Cathrine Ørskov, Marco Tozzi, Erin L Brown, Emil Andersen, Tao Ma, Ulrich Müller, Romain Barrès, Viggo B Kristiansen, Zachary Gerhart-Hines, Yu-Hua Tseng, Brice Emanuelli

Abstract

Insulin orchestrates metabolic homeostasis through a complex signaling network for which the precise mechanisms controlling its fine-tuning are not completely understood. Here, we report that Afadin, a scaffold protein, is phosphorylated on S1795 (S1718 in humans) in response to insulin in adipocytes, and this phosphorylation is impaired with obesity and insulin resistance. In turn, loss of Afadin enhances the response to insulin in adipose tissues via upregulation of the insulin receptor protein levels. This happens in a cell-autonomous and phosphorylation-dependent manner. Insulin-stimulated Afadin-S1795 phosphorylation modulates Afadin binding with interaction partners in adipocytes, among which HDAC6 preferentially interacts with phosphorylated Afadin and acts as a key intermediate to suppress insulin receptor protein levels. Adipose tissue-specific Afadin depletion protects against insulin resistance and improves glucose homeostasis in diet-induced obese mice, independently of adiposity. Altogether, we uncover a novel insulin-induced cellular feedback mechanism governed by the interaction of Afadin with HDAC6 to negatively control insulin action in adipocytes, which may offer new strategies to alleviate insulin resistance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。